{
  "meta": {
    "id": "test38",
    "title": "Mid Day Module (Medicine-9) - 2024-12-21",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which genetic abnormality defines double-hit lymphoma (DHL)?",
      "options": [
        {
          "label": "A",
          "text": "t(14;18) with MYC overexpression",
          "correct": false
        },
        {
          "label": "B",
          "text": "MYC translocation with BCL2 or BCL6 rearrangement",
          "correct": true
        },
        {
          "label": "C",
          "text": "BCL2 translocation with BCL6 rearrangement",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trisomy 12 with BCL6 rearrangement",
          "correct": false
        }
      ],
      "correct_answer": "B. MYC translocation with BCL2 or BCL6 rearrangement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) MYC translocation with BCL2 or BCL6 rearrangement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. t(14;18) with MYC overexpression: While t(14;18) is associated with BCL2 overexpression and is seen in follicular lymphoma, it alone does not define DHL. DHL requires the additional presence of a MYC translocation.</li><li>\u2022 Option</li><li>\u2022 A. t(14;18) with MYC overexpression:</li><li>\u2022 Option C. BCL2 translocation with BCL6 rearrangement: This combination of rearrangements is not characteristic of DHL. DHL specifically requires a MYC translocation.</li><li>\u2022 Option</li><li>\u2022 C. BCL2 translocation with BCL6 rearrangement:</li><li>\u2022 Option D. Trisomy 12 with BCL6 rearrangement: Trisomy 12 is associated with chronic lymphocytic leukemia (CLL), and while BCL6 rearrangement can occur in various lymphomas, this combination does not define DHL.</li><li>\u2022 Option</li><li>\u2022 D. Trisomy 12 with BCL6 rearrangement:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 The combined dysregulation of MYC and BCL2/BCL6 is the defining feature of DHL.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f90cd01f",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a standard treatment option for mantle cell lymphoma (MCL)?",
      "options": [
        {
          "label": "A",
          "text": "R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bendamustine-rituximab (BR)",
          "correct": false
        },
        {
          "label": "C",
          "text": "HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)",
          "correct": false
        },
        {
          "label": "D",
          "text": "ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)",
          "correct": true
        }
      ],
      "correct_answer": "D. ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "574e1247",
      "audio": ""
    },
    {
      "text": "Which of the following chemotherapy regimens is NOT typically used as a first-line treatment for symptomatic follicular lymphoma (FL)?",
      "options": [
        {
          "label": "A",
          "text": "R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)",
          "correct": false
        },
        {
          "label": "B",
          "text": "R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bendamustine-rituximab (BR)",
          "correct": false
        },
        {
          "label": "D",
          "text": "HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)",
          "correct": true
        }
      ],
      "correct_answer": "D. HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone): This is a widely used and effective first-line treatment for FL. It combines the monoclonal antibody rituximab with a standard chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone).</li><li>\u2022 Option</li><li>\u2022 A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone):</li><li>\u2022 Option B. R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone): This is another commonly used first-line regimen for FL, particularly in older or less fit patients. It is similar to R-CHOP but uses vincristine instead of doxorubicin, which is associated with less cardiotoxicity.</li><li>\u2022 Option</li><li>\u2022 B. R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone):</li><li>\u2022 Option C. Bendamustine-rituximab (BR): This is a well-tolerated and effective regimen that has gained popularity as a first-line treatment for FL, especially in patients who may not tolerate the anthracycline component of R-CHOP.</li><li>\u2022 Option</li><li>\u2022 C. Bendamustine-rituximab (BR):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 FL is typically treated with less intensive chemotherapy regimens compared to aggressive lymphomas.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "80c3138d",
      "audio": ""
    },
    {
      "text": "Which of the following laboratory findings is characteristic of hairy cell leukemia (HCL)?",
      "options": [
        {
          "label": "A",
          "text": "Positive tartrate-resistant acid phosphatase (TRAP) stain",
          "correct": true
        },
        {
          "label": "B",
          "text": "Positive myeloperoxidase (MPO) stain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased serum uric acid levels",
          "correct": false
        },
        {
          "label": "D",
          "text": "BCR-ABL1 fusion gene",
          "correct": false
        }
      ],
      "correct_answer": "A. Positive tartrate-resistant acid phosphatase (TRAP) stain",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Positive tartrate-resistant acid phosphatase (TRAP) stain</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Positive myeloperoxidase (MPO) stain: MPO is an enzyme found in myeloid cells (neutrophils, eosinophils, and monocytes) and is used to diagnose myeloid leukemias. It is not typically positive in HCL.</li><li>\u2022 Option</li><li>\u2022 B. Positive myeloperoxidase (MPO) stain:</li><li>\u2022 Option C. Increased serum uric acid levels: While elevated uric acid levels can be seen in various hematologic malignancies due to increased cell turnover, it is not a specific finding for HCL.</li><li>\u2022 Option</li><li>\u2022 C. Increased serum uric acid levels:</li><li>\u2022 Option D. BCR-ABL1 fusion gene: This genetic abnormality is the hallmark of chronic myeloid leukemia (CML) and is not associated with HCL.</li><li>\u2022 Option</li><li>\u2022 D. BCR-ABL1 fusion gene:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 A positive TRAP stain is a useful diagnostic clue for hairy cell leukemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f96f3ba5",
      "audio": ""
    },
    {
      "text": "Which of the following is a potential adverse effect of venetoclax, a BCL2 inhibitor used in CLL/SLL treatment?",
      "options": [
        {
          "label": "A",
          "text": "Tumor lysis syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Atrial fibrillation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diarrhea",
          "correct": false
        },
        {
          "label": "D",
          "text": "Peripheral neuropathy",
          "correct": false
        }
      ],
      "correct_answer": "A. Tumor lysis syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Tumor lysis syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Atrial fibrillation: While cardiac arrhythmias can be a side effect of some cancer therapies, atrial fibrillation is not a common side effect specifically associated with venetoclax.</li><li>\u2022 Option</li><li>\u2022 B. Atrial fibrillation:</li><li>\u2022 Option C. Diarrhea: Diarrhea is a common side effect of many chemotherapies but is not a characteristic side effect of venetoclax.</li><li>\u2022 Option</li><li>\u2022 C. Diarrhea:</li><li>\u2022 Option D. Peripheral neuropathy: Peripheral neuropathy (damage to peripheral nerves causing numbness, tingling, or pain) can be a side effect of certain chemotherapy agents, but it is not typically associated with venetoclax.</li><li>\u2022 Option</li><li>\u2022 D. Peripheral neuropathy:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Monitoring for and preventing TLS is crucial when initiating venetoclax therapy in CLL/SLL.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37e690ae",
      "audio": ""
    },
    {
      "text": "Which of the following genetic abnormalities is associated with a poor prognosis in CLL/SLL?",
      "options": [
        {
          "label": "A",
          "text": "Del(13q)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Del(17p)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mutated IgVH genes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trisomy 12",
          "correct": false
        }
      ],
      "correct_answer": "B. Del(17p)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Del(17p)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Del(13q): This is the most common genetic abnormality in CLL/SLL and is associated with a favorable prognosis. It typically involves deletion of the microRNA genes miR-15a and miR-16-1, which regulate B-cell survival.</li><li>\u2022 Option</li><li>\u2022 A. Del(13q):</li><li>\u2022 Option C. Mutated IgVH genes: CLL/SLL cases with mutated IgVH genes generally have a more indolent course and better prognosis compared to those with unmutated IgVH genes.</li><li>\u2022 Option</li><li>\u2022 C. Mutated IgVH genes:</li><li>\u2022 Option D. Trisomy 12: This is an intermediate-risk genetic abnormality in CLL/SLL, with a prognosis between that of del(13q) and del(17p). It can be associated with atypical morphology and increased proliferative activity.</li><li>\u2022 Option</li><li>\u2022 D. Trisomy 12:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 del(17p) is a high-risk genetic abnormality in CLL/SLL.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "df2759cf",
      "audio": ""
    },
    {
      "text": "A 60-year-old man presents with generalized erythroderma (redness of the skin), intense pruritus, and lymphadenopathy. Peripheral blood smear reveals atypical lymphocytes with cerebriform nuclei. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Atopic dermatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Psoriasis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mycosis fungoides (MF)",
          "correct": false
        },
        {
          "label": "D",
          "text": "S\u00e9zary syndrome (SS)",
          "correct": true
        }
      ],
      "correct_answer": "D. S\u00e9zary syndrome (SS)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) S\u00e9zary syndrome (SS)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atopic dermatitis: While atopic dermatitis can cause itchy skin, it usually presents with localized patches of dry, scaly skin and does not typically cause erythroderma or lymphadenopathy. It also doesn't have the characteristic cerebriform nuclei seen in SS.</li><li>\u2022 Option</li><li>\u2022 A. Atopic dermatitis:</li><li>\u2022 Option B. Psoriasis: Psoriasis can also cause itchy, scaly skin, but the plaques are usually well-demarcated and silvery. It does not typically progress to erythroderma or involve lymph nodes. Again, the cerebriform nuclei are not a feature of psoriasis.</li><li>\u2022 Option</li><li>\u2022 B. Psoriasis:</li><li>\u2022 Option C. Mycosis fungoides (MF): MF is another type of CTCL and can share some skin features with SS. However, it usually progresses more slowly and doesn't always present with erythroderma. In the early stages of MF, the atypical lymphocytes are typically confined to the skin, not circulating in the blood.</li><li>\u2022 Option</li><li>\u2022 C. Mycosis fungoides (MF):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 SS is characterized by erythroderma, circulating S\u00e9zary cells, and lymphadenopathy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f65ba2f3",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman with a history of breast implants presents with a rapidly enlarging axillary lymph node. Excisional biopsy reveals large atypical cells with horseshoe-shaped nuclei and abundant cytoplasm. Immunohistochemical staining shows strong expression of CD30. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hodgkin lymphoma (HL)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diffuse large B-cell lymphoma (DLBCL)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anaplastic large cell lymphoma (ALCL)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)",
          "correct": false
        }
      ],
      "correct_answer": "C. Anaplastic large cell lymphoma (ALCL)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anaplastic large cell lymphoma (ALCL)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hodgkin lymphoma (HL): While HL can express CD30, it lacks the characteristic hallmark cells with horseshoe-shaped nuclei seen in ALCL. RS cells are usually larger and have a bilobed or multi-lobed nucleus.</li><li>\u2022 Option</li><li>\u2022 A. Hodgkin lymphoma (HL):</li><li>\u2022 Option B. Diffuse large B-cell lymphoma (DLBCL): DLBCL is a B-cell lymphoma and would not express CD30. The cells in DLBCL are also not typically described as having horseshoe-shaped nuclei.</li><li>\u2022 Option</li><li>\u2022 B. Diffuse large B-cell lymphoma (DLBCL):</li><li>\u2022 Option D. Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS): PTCL-NOS is a heterogeneous group of T-cell lymphomas. While it can share some features with ALCL, it does not have the specific hallmark cells or the same association with breast implants.</li><li>\u2022 Option</li><li>\u2022 D. Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 ALCL is a T-cell lymphoma characterized by large atypical cells, CD30 expression, and potential association with breast implants.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1415a12f",
      "audio": ""
    },
    {
      "text": "A 68-year-old man presents with fatigue, bone pain, and elevated serum creatinine. Serum protein electrophoresis reveals an M-spike, and bone marrow biopsy shows 30% plasma cells. Skeletal survey reveals multiple lytic lesions. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Monoclonal gammopathy of undetermined significance (MGUS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Smoldering multiple myeloma (SMM)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Multiple myeloma (MM)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Waldenstr\u00f6m's macroglobulinemia (WM)",
          "correct": false
        }
      ],
      "correct_answer": "C. Multiple myeloma (MM)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Multiple myeloma (MM)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Monoclonal gammopathy of undetermined significance (MGUS): MGUS is a benign condition characterized by a small M-spike and low levels of plasma cells in the bone marrow (<10%). Crucially, MGUS patients do not have end-organ damage (CRAB criteria).</li><li>\u2022 Option</li><li>\u2022 A. Monoclonal gammopathy of undetermined significance (MGUS):</li><li>\u2022 Option B. Smoldering multiple myeloma (SMM): SMM is an intermediate stage between MGUS and multiple myeloma. While it has a higher risk of progression to myeloma, SMM patients typically lack the CRAB criteria that define multiple myeloma.</li><li>\u2022 Option</li><li>\u2022 B. Smoldering multiple myeloma (SMM):</li><li>\u2022 Option D. Waldenstr\u00f6m's macroglobulinemia (WM): WM is a type of lymphoma characterized by the overproduction of IgM antibodies. While it can share some features with multiple myeloma (like an M-spike), the clinical presentation and bone marrow findings are different. WM typically does not cause lytic bone lesions.</li><li>\u2022 Option</li><li>\u2022 D. Waldenstr\u00f6m's macroglobulinemia (WM):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Multiple myeloma is characterized by the presence of CRAB criteria, which distinguish it from MGUS and SMM.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b07436c0",
      "audio": ""
    },
    {
      "text": "A patient with newly diagnosed multiple myeloma has a bone marrow biopsy revealing a t(14;16) translocation. Which of the following statements is true regarding this patient's prognosis?",
      "options": [
        {
          "label": "A",
          "text": "The patient has standard-risk myeloma and a good prognosis.",
          "correct": false
        },
        {
          "label": "B",
          "text": "The patient has high-risk myeloma and a poor prognosis.",
          "correct": true
        },
        {
          "label": "C",
          "text": "The t(14;16) translocation is not a significant prognostic factor in multiple myeloma.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The patient requires immediate allogeneic stem cell transplantation.",
          "correct": false
        }
      ],
      "correct_answer": "B. The patient has high-risk myeloma and a poor prognosis.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) The patient has high-risk myeloma and a poor prognosis.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5e06815",
      "audio": ""
    },
    {
      "text": "A 75-year-old male presents with fatigue, weight loss, and blurred vision. Laboratory findings show elevated IgM levels and anemia. Bone marrow biopsy reveals lymphoid cells with plasmacytic differentiation. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Multiple Myeloma (MM)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Waldenstr\u00f6m Macroglobulinemia (WM)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Monoclonal Gammopathy of Undetermined Significance (MGUS)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Smoldering Multiple Myeloma (SMM)",
          "correct": false
        }
      ],
      "correct_answer": "B. Waldenstr\u00f6m Macroglobulinemia (WM)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Waldenstr\u00f6m Macroglobulinemia (WM)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Multiple Myeloma (MM): While MM can cause fatigue, weight loss, and anemia, it is less likely in this case due to the absence of lytic bone lesions (holes in the bones) and hypercalcemia (high calcium levels). MM also typically presents with elevated IgG or IgA, not IgM.</li><li>\u2022 Option</li><li>\u2022 A. Multiple Myeloma (MM):</li><li>\u2022 Option C. Monoclonal Gammopathy of Undetermined Significance (MGUS): MGUS is a benign condition where a small amount of monoclonal protein is present in the blood. It usually doesn't cause symptoms and wouldn't explain the patient's fatigue, weight loss, blurred vision, or anemia.</li><li>\u2022 Option C. Monoclonal Gammopathy of Undetermined Significance (MGUS):</li><li>\u2022 Option D. Smoldering Multiple Myeloma (SMM): SMM is a precursor to multiple myeloma. While it shares some similarities with MM, it typically doesn't cause symptoms or organ damage. This patient's presentation with fatigue, weight loss, and blurred vision suggests a more active disease process than SMM.</li><li>\u2022 Option</li><li>\u2022 D. Smoldering Multiple Myeloma (SMM):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 WM often presents with hyperviscosity symptoms and bone marrow infiltration by lymphoplasmacytic cells.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c15e57b",
      "audio": ""
    },
    {
      "text": "A patient undergoing allogeneic stem cell transplantation (allo-SCT) develops a maculopapular rash, diarrhea, and elevated liver enzymes. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute graft-versus-host disease (GVHD)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chronic graft-versus-host disease (GVHD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cytomegalovirus (CMV) reactivation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Engraftment syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute graft-versus-host disease (GVHD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute graft-versus-host disease (GVHD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Chronic graft-versus-host disease (GVHD): While chronic GVHD can also affect the skin, gastrointestinal tract, and liver, it typically develops later after transplantation (months to years), and presents with different manifestations like skin thickening, dry eyes/mouth, and lung problems.</li><li>\u2022 Option</li><li>\u2022 B. Chronic graft-versus-host disease (GVHD):</li><li>\u2022 Option C. Cytomegalovirus (CMV) reactivation: CMV reactivation is a common complication of allo-SCT, but it typically presents with fever, fatigue, and less specific gastrointestinal symptoms. It doesn't usually cause the characteristic skin rash seen in GVHD.</li><li>\u2022 Option</li><li>\u2022 C. Cytomegalovirus (CMV) reactivation:</li><li>\u2022 Option D. Engraftment syndrome: This is a non-infectious inflammatory syndrome that can occur shortly after transplant. It may present with fever, rash, and pulmonary edema, but it usually lacks the specific gastrointestinal symptoms of GVHD.</li><li>\u2022 Option</li><li>\u2022 D. Engraftment syndrome:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Acute GVHD is a serious complication of allo-SCT and requires prompt diagnosis and treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a06e46f",
      "audio": ""
    },
    {
      "text": "A patient with a history of liver disease receives a massive blood transfusion. Which complication should be monitored closely due to the presence of citrate in transfused blood?",
      "options": [
        {
          "label": "A",
          "text": "Hypothermia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperkalemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypocalcemia and metabolic alkalosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Thrombocytopenia",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypocalcemia and metabolic alkalosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hypocalcemia and metabolic alkalosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hypothermia: Hypothermia can be a complication of massive transfusion, but it's primarily caused by the rapid infusion of cold blood products, not the citrate preservative.</li><li>\u2022 Option A. Hypothermia:</li><li>\u2022 Option B. Hyperkalemia: While hyperkalemia can occur during massive transfusion, it's usually due to the breakdown of red blood cells releasing potassium, not the citrate itself.</li><li>\u2022 Option B. Hyperkalemia:</li><li>\u2022 Option D. Thrombocytopenia: Thrombocytopenia (low platelet count) can occur due to dilution from massive transfusion or consumption of platelets in trauma or sepsis. It's not directly related to citrate.</li><li>\u2022 Option D. Thrombocytopenia:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Patients with liver disease are at increased risk for hypocalcemia and metabolic alkalosis following blood transfusion due to impaired citrate metabolism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8777aaf3",
      "audio": ""
    },
    {
      "text": "A patient develops fever, chills, flank pain, and hypotension after starting a red blood cell transfusion. Urine output is significantly reduced, and the urine appears dark. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Febrile non-hemolytic transfusion reaction (FNHTR)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transfusion-related acute lung injury (TRALI)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Allergic transfusion reaction",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute hemolytic transfusion reaction (AHTR)",
          "correct": true
        }
      ],
      "correct_answer": "D. Acute hemolytic transfusion reaction (AHTR)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Acute hemolytic transfusion reaction (AHTR)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Febrile non-hemolytic transfusion reaction (FNHTR): While FNHTR is the most common transfusion reaction, it typically presents with fever and chills but not hypotension, flank pain, or dark urine.</li><li>\u2022 Option A. Febrile non-hemolytic transfusion reaction (FNHTR):</li><li>\u2022 Option B. Transfusion-related acute lung injury (TRALI): TRALI is characterized by acute respiratory distress (e.g., dyspnea, hypoxemia) and non-cardiogenic pulmonary edema, which are not present in this case.</li><li>\u2022 Option B. Transfusion-related acute lung injury (TRALI):</li><li>\u2022 Option C. Allergic transfusion reaction: Allergic reactions usually manifest with urticaria (hives), itching, and sometimes bronchospasm. They typically do not cause flank pain, dark urine, or significant hypotension.</li><li>\u2022 Option C. Allergic transfusion reaction:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 AHTR is a life-threatening emergency requiring immediate recognition and intervention.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3c1618f",
      "audio": ""
    },
    {
      "text": "A patient with a history of recurrent allergic reactions to blood transfusions presents for a scheduled surgery. Which of the following tests is most appropriate to assess their risk of anaphylaxis?",
      "options": [
        {
          "label": "A",
          "text": "Direct antiglobulin test (DAT)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serum IgA levels",
          "correct": true
        },
        {
          "label": "C",
          "text": "HLA antibody screening",
          "correct": false
        },
        {
          "label": "D",
          "text": "Platelet aggregation studies",
          "correct": false
        }
      ],
      "correct_answer": "B. Serum IgA levels",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Serum IgA levels</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Direct antiglobulin test (DAT): The DAT detects antibodies or complement proteins bound to red blood cells. While it is useful in diagnosing certain types of transfusion reactions (like hemolytic reactions), it doesn't directly assess the risk of IgA-mediated anaphylaxis.</li><li>\u2022 Option A. Direct antiglobulin test (DAT):</li><li>\u2022 Option C. HLA antibody screening: HLA antibodies are directed against human leukocyte antigens (HLA) on white blood cells. While these antibodies can cause transfusion reactions, they are not the primary culprit in IgA deficiency-related anaphylaxis.</li><li>\u2022 Option C. HLA antibody screening:</li><li>\u2022 Option D. Platelet aggregation studies: These tests assess platelet function and are primarily used to investigate bleeding disorders. They are not relevant to the diagnosis of IgA deficiency or the assessment of anaphylaxis risk.</li><li>\u2022 Option D. Platelet aggregation studies:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Serum immunoglobulin levels are essential for diagnosing IgA deficiency in patients with a history of transfusion reactions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9eb14fbb",
      "audio": ""
    },
    {
      "text": "A patient develops acute respiratory distress, fever, and hypotension within 2 hours of receiving a blood transfusion. On examination, there was no rise in JVP/pedal edema Chest X-ray reveals bilateral pulmonary infiltrates. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute hemolytic transfusion reaction (AHTR)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transfusion-associated circulatory overload (TACO)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transfusion-related acute lung injury (TRALI)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anaphylactic transfusion reaction",
          "correct": false
        }
      ],
      "correct_answer": "C. Transfusion-related acute lung injury (TRALI)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Transfusion-related acute lung injury (TRALI)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute hemolytic transfusion reaction (AHTR): While AHTR can also cause fever and hypotension, it typically presents with additional symptoms like flank pain, hemoglobinuria (dark urine), and signs of hemolysis (increased bilirubin, decreased haptoglobin).</li><li>\u2022 Option A. Acute hemolytic transfusion reaction (AHTR):</li><li>\u2022 Option B. Transfusion-associated circulatory overload (TACO): TACO is characterized by signs of fluid overload, such as hypertension, elevated jugular venous pressure (JVP), and peripheral edema. Patients with TACO may also have respiratory distress due to pulmonary edema, but it is usually not associated with fever or hypotension.</li><li>\u2022 Option B. Transfusion-associated circulatory overload (TACO):</li><li>\u2022 Option D. Anaphylactic transfusion reaction: Anaphylactic reactions typically manifest with urticaria (hives), angioedema, and bronchospasm. While hypotension can occur, it is usually accompanied by other allergic symptoms not present in this case.</li><li>\u2022 Option D. Anaphylactic transfusion reaction:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 TRALI is a serious complication of transfusion characterized by acute lung injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef9e8442",
      "audio": ""
    },
    {
      "text": "A patient develops jaundice, fever, and a gradual drop in hemoglobin levels one week after receiving a blood transfusion. The pre-transfusion antibody screen was negative. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute hemolytic transfusion reaction (AHTR)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Febrile non-hemolytic transfusion reaction (FNHTR)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transfusion-related acute lung injury (TRALI)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Delayed hemolytic transfusion reaction (DHTR)",
          "correct": true
        }
      ],
      "correct_answer": "D. Delayed hemolytic transfusion reaction (DHTR)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Delayed hemolytic transfusion reaction (DHTR)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute hemolytic transfusion reaction (AHTR): AHTR typically presents with rapid onset (within hours) of fever, chills, flank pain, and hemoglobinuria. It is usually caused by ABO incompatibility, which would have been detected in the pre-transfusion testing.</li><li>\u2022 Option A. Acute hemolytic transfusion reaction (AHTR):</li><li>\u2022 Option B. Febrile non-hemolytic transfusion reaction (FNHTR): FNHTR is the most common type of transfusion reaction and usually presents with fever and chills within a few hours of transfusion. It is not associated with jaundice or a drop in hemoglobin levels.</li><li>\u2022 Option B. Febrile non-hemolytic transfusion reaction (FNHTR):</li><li>\u2022 Option C. Transfusion-related acute lung injury (TRALI): TRALI presents with acute respiratory distress, hypotension, and pulmonary edema shortly after transfusion. It does not typically cause jaundice or a delayed drop in hemoglobin.</li><li>\u2022 Option C. Transfusion-related acute lung injury (TRALI):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 DHTRs are typically delayed and caused by undetected antibodies against minor blood group antigens.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "32837173",
      "audio": ""
    },
    {
      "text": "A 78-year-old patient is diagnosed with newly diagnosed AML but has significant comorbidities and is considered unfit for intensive induction chemotherapy (\"7+3\"). Which of the following is the most appropriate treatment option?",
      "options": [
        {
          "label": "A",
          "text": "Standard \"7+3\" induction chemotherapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Midostaurin + Gemtuzumab ozogamicin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypomethylating agent (HMA) + Venetoclax",
          "correct": true
        },
        {
          "label": "D",
          "text": "Allogeneic stem cell transplant",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypomethylating agent (HMA) + Venetoclax",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hypomethylating agent (HMA) + Venetoclax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Standard \"7+3\" induction chemotherapy : Standard \"7+3\" is too intensive for unfit patients.</li><li>\u2022 Option A.</li><li>\u2022 Standard \"7+3\" induction chemotherapy</li><li>\u2022 Option B. Midostaurin + Gemtuzumab ozogamicin : Midostaurin and Gemtuzumab are often added to standard induction, not used in isolation for unfit patients.</li><li>\u2022 Option B. Midostaurin + Gemtuzumab ozogamicin</li><li>\u2022 Option D. Allogeneic stem cell transplant : Allogeneic stem cell transplant is a potential curative option but is generally not feasible for older patients with comorbidities.</li><li>\u2022 Option D. Allogeneic stem cell transplant</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 HMA + Venetoclax offers a less intensive, yet effective, treatment option for older or unfit AML patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c6688e67",
      "audio": ""
    },
    {
      "text": "A 15-year-old male presents with a rapidly enlarging jaw mass and systemic B symptoms. Biopsy reveals medium-sized lymphoid cells with a starry sky pattern. Which of the following cytogenetic abnormalities is most likely associated with this lymphoma?",
      "options": [
        {
          "label": "A",
          "text": "t(11;14)",
          "correct": false
        },
        {
          "label": "B",
          "text": "t(14;18)",
          "correct": false
        },
        {
          "label": "C",
          "text": "t(8;14)",
          "correct": true
        },
        {
          "label": "D",
          "text": "t(11;18)",
          "correct": false
        }
      ],
      "correct_answer": "C. t(8;14)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) t(8;14)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. t(11;14): This translocation is characteristic of Mantle Cell Lymphoma. It involves the cyclin D1 gene and leads to increased cell cycle progression.</li><li>\u2022 Option</li><li>\u2022 A. t(11;14):</li><li>\u2022 Option B. t(14;18): This translocation is associated with Follicular Lymphoma. It involves the BCL2 gene, which inhibits apoptosis and promotes cell survival.</li><li>\u2022 Option</li><li>\u2022 B. t(14;18):</li><li>\u2022 Option D. t(11;18): This translocation is also associated with Mantle Cell Lymphoma, like option A.</li><li>\u2022 Option</li><li>\u2022 D. t(11;18):</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Burkitt lymphoma is a highly aggressive B-cell lymphoma characterized by a specific translocation, t(8;14).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "18c2b32a",
      "audio": ""
    },
    {
      "text": "A 35-year-old man with HIV presents with multiple violet-colored skin lesions and lymphadenopathy. The lesion is shown below. Which of the following is the most common etiological agent for his skin condition?",
      "options": [
        {
          "label": "A",
          "text": "Human herpesvirus 8 (HHV-8)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Epstein-Barr virus (EBV)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Human papillomavirus (HPV)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Human T-lymphotropic virus 1 (HTLV-1)",
          "correct": false
        }
      ],
      "correct_answer": "A. Human herpesvirus 8 (HHV-8)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-162222.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Epstein-Barr virus (EBV): While EBV is associated with several malignancies (lymphoma, nasopharyngeal carcinoma), it doesn't typically cause the characteristic skin lesions seen in Kaposi sarcoma.</li><li>\u2022 Option B. Epstein-Barr virus (EBV):</li><li>\u2022 Option C. Human papillomavirus (HPV): HPV is primarily associated with cervical cancer and other anogenital cancers. It doesn't cause the type of lesions seen in this patient.</li><li>\u2022 Option C. Human papillomavirus (HPV):</li><li>\u2022 Option D. Human T-lymphotropic virus 1 (HTLV-1): HTLV-1 is associated with adult T-cell leukemia/lymphoma, a type of blood cancer. It doesn't usually cause the distinctive skin lesions of Kaposi sarcoma.</li><li>\u2022 Option D. Human T-lymphotropic virus 1 (HTLV-1):</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 HHV-8 is the causative agent of Kaposi sarcoma, a malignancy often seen in HIV-infected individuals.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eb40e807",
      "audio": ""
    },
    {
      "text": "Which of the following types of UV radiation is MOST strongly linked to the development of skin cancer?",
      "options": [
        {
          "label": "A",
          "text": "gamma rays",
          "correct": false
        },
        {
          "label": "B",
          "text": "UVB",
          "correct": true
        },
        {
          "label": "C",
          "text": "x-rays",
          "correct": false
        },
        {
          "label": "D",
          "text": "alpha - rays",
          "correct": false
        }
      ],
      "correct_answer": "B. UVB",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) UVB</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. gamma rays: Gamma rays are a type of ionizing radiation with very short wavelengths and high energy. While they are carcinogenic, they are not the primary type of radiation associated with skin cancer.</li><li>\u2022 Option A. gamma rays:</li><li>\u2022 Option C. x-rays: X-rays are also a type of ionizing radiation with shorter wavelengths than UV radiation. They are used in medical imaging and can also be carcinogenic, but their primary association is not with skin cancer.</li><li>\u2022 Option C. x-rays:</li><li>\u2022 Option D. alpha-rays: Alpha rays are a type of particle radiation consisting of two protons and two neutrons. They have low penetrating power and are not associated with skin cancer.</li><li>\u2022 Option D. alpha-rays:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 UVB radiation is the most significant contributor to skin cancer development.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fcb999f5",
      "audio": ""
    },
    {
      "text": "A 50-year-old man, with a history of silicosis presents with progressive dyspnea and pleural plaques on imaging. Which of the following malignancies is he most likely at risk for developing in future?",
      "options": [
        {
          "label": "A",
          "text": "Small cell lung cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mesothelioma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Squamous cell carcinoma of the lung",
          "correct": false
        },
        {
          "label": "D",
          "text": "Adenocarcinoma of the lung",
          "correct": false
        }
      ],
      "correct_answer": "B. Mesothelioma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Mesothelioma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Small cell lung cancer: While smoking is the primary risk factor, it's not directly associated with silicosis or pleural plaques.</li><li>\u2022 Option A. Small cell lung cancer:</li><li>\u2022 Option C. Squamous cell carcinoma of the lung: Also primarily linked to smoking, not specifically to silicosis or asbestos.</li><li>\u2022 Option C. Squamous cell carcinoma of the lung:</li><li>\u2022 Option D. Adenocarcinoma of the lung: The most common type of lung cancer but not directly associated with silicosis or asbestos.</li><li>\u2022 Option D. Adenocarcinoma of the lung:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The combination of silicosis and pleural plaques is a strong indicator of asbestos exposure and significantly increases the risk of developing mesothelioma. Early detection and monitoring are crucial for individuals with this history.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0632c529",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of smoking presents with cough, hemoptysis, and a lung mass on chest X-ray. Which of the following tumor markers is MOST likely to be elevated?",
      "options": [
        {
          "label": "A",
          "text": "CEA",
          "correct": false
        },
        {
          "label": "B",
          "text": "AFP",
          "correct": false
        },
        {
          "label": "C",
          "text": "NSE",
          "correct": true
        },
        {
          "label": "D",
          "text": "CA 19-9",
          "correct": false
        }
      ],
      "correct_answer": "C. NSE",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. CEA (Carcinoembryonic Antigen): While CEA can be elevated in some lung cancers, it's more commonly associated with colorectal, breast, and other gastrointestinal cancers.</li><li>\u2022 Option A. CEA (Carcinoembryonic Antigen):</li><li>\u2022 Option B. AFP (Alpha-fetoprotein): AFP is primarily used as a marker for liver cancer (hepatocellular carcinoma) and certain germ cell tumors. It's not typically elevated in lung cancers.</li><li>\u2022 Option B. AFP (Alpha-fetoprotein):</li><li>\u2022 Option D. CA 19-9 (Carbohydrate Antigen 19-9): CA 19-9 is most commonly used as a marker for pancreatic cancer and some other gastrointestinal malignancies. It's not a primary marker for lung cancers.</li><li>\u2022 Option D. CA 19-9 (Carbohydrate Antigen 19-9):</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 NSE is a useful marker for the diagnosis and monitoring of neuroendocrine tumors, particularly SCLC.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb9dbcb8",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with a palpable breast mass and nipple discharge. Which tumor marker would be MOST appropriate to order in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "CA 19-9",
          "correct": false
        },
        {
          "label": "B",
          "text": "CA 15-3",
          "correct": true
        },
        {
          "label": "C",
          "text": "CA-125",
          "correct": false
        },
        {
          "label": "D",
          "text": "CEA",
          "correct": false
        }
      ],
      "correct_answer": "B. CA 15-3",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) CA 15-3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. CA 19-9: This marker is primarily associated with pancreatic cancer and some gastrointestinal malignancies. It's not routinely used in the initial evaluation of breast masses.</li><li>\u2022 Option A. CA 19-9:</li><li>\u2022 Option C. CA-125: This marker is primarily associated with ovarian cancer and is not routinely used in the evaluation of breast masses.</li><li>\u2022 Option C. CA-125:</li><li>\u2022 Option D. CEA: This marker can be elevated in various cancers, including breast cancer. However, it is not specific for breast cancer and is typically used to monitor response to treatment or detect recurrence rather than in the initial diagnosis of a breast mass.</li><li>\u2022 Option D. CEA:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 CA 15-3 is a useful marker for monitoring breast cancer progression and treatment response.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2121d8f6",
      "audio": ""
    },
    {
      "text": "A 32-year-old woman with a known BRCA1 mutation desires the most effective risk reduction strategy for breast cancer. Which of the following options would you recommend?",
      "options": [
        {
          "label": "A",
          "text": "Bilateral salpingo-oophorectomy (rrBSO)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Risk-reducing bilateral mastectomy (rrBLM)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Annual mammogram starting at age 40",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tamoxifen chemoprevention",
          "correct": false
        }
      ],
      "correct_answer": "B. Risk-reducing bilateral mastectomy (rrBLM)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Risk-reducing bilateral mastectomy (rrBLM)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bilateral salpingo-oophorectomy (rrBSO): While rrBSO is a risk-reducing surgery, it primarily targets ovarian cancer risk. Although it can somewhat decrease breast cancer risk in premenopausal women, it is not as effective as rrBLM in directly addressing breast cancer.</li><li>\u2022 Option A. Bilateral salpingo-oophorectomy (rrBSO):</li><li>\u2022 Option C. Annual mammogram starting at age 40: Mammography is a screening tool for early detection, not a preventive measure. In women with BRCA1 mutations, who often develop breast cancer at a younger age, mammography alone may not be sufficient for early detection.</li><li>\u2022 Option C. Annual mammogram starting at age 40:</li><li>\u2022 Option D. Tamoxifen chemoprevention: While tamoxifen can reduce the risk of breast cancer in women with BRCA2 mutations, its effectiveness is not as high as rrBLM in BRCA1 carriers. Additionally, it comes with potential side effects and is not suitable for all women.</li><li>\u2022 Option D. Tamoxifen chemoprevention:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 rrBLM is the most effective risk reduction strategy for breast cancer in BRCA1/2 mutation carriers.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f0b6d57d",
      "audio": ""
    },
    {
      "text": "Which of the following HPV types are covered by BOTH Gardasil and Cervarix vaccines?",
      "options": [
        {
          "label": "A",
          "text": "6 and 11",
          "correct": false
        },
        {
          "label": "B",
          "text": "16 and 18",
          "correct": true
        },
        {
          "label": "C",
          "text": "6, 11, and 16",
          "correct": false
        },
        {
          "label": "D",
          "text": "11, 16, and 18",
          "correct": false
        }
      ],
      "correct_answer": "B. 16 and 18",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 16 and 18</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "55b4b912",
      "audio": ""
    },
    {
      "text": "A 40-year-old woman has a father who was diagnosed with colorectal cancer at age 55. When should she initiate screening for colorectal cancer, according to the image?",
      "options": [
        {
          "label": "A",
          "text": "Immediately",
          "correct": false
        },
        {
          "label": "B",
          "text": "At age 45",
          "correct": false
        },
        {
          "label": "C",
          "text": "At age 50",
          "correct": false
        },
        {
          "label": "D",
          "text": "10 years before her father's age of diagnosis (i.e., at age 45)",
          "correct": true
        }
      ],
      "correct_answer": "D. 10 years before her father's age of diagnosis (i.e., at age 45)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 10 years before her father's age of diagnosis (i.e., at age 45)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Immediately: While having a family history of colorectal cancer (CRC) does increase risk, immediate screening is not recommended unless there are other concerning symptoms or risk factors.</li><li>\u2022 Option A. Immediately:</li><li>\u2022 Option B. At age 45: This is the general recommended age to begin screening for those with average risk, but with a family history of CRC, earlier screening is appropriate.</li><li>\u2022 Option B. At age 45:</li><li>\u2022 Option C. At age 50: This is too late for someone with a first-degree relative diagnosed with CRC at age 55. Earlier screening is necessary to detect potential problems early.</li><li>\u2022 Option C. At age 50:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Individuals with a family history of colorectal cancer should start screening 10 years younger than the age at which their first-degree relative was diagnosed. This allows for early detection and intervention of precancerous polyps or early-stage cancer, ultimately improving outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a688df12",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient with metastatic lung cancer reports fatigue but is still able to perform most of their daily activities, including light housework and grocery shopping. Which ECOG performance status is MOST appropriate for this patient?",
      "options": [
        {
          "label": "A",
          "text": "0",
          "correct": false
        },
        {
          "label": "B",
          "text": "1",
          "correct": true
        },
        {
          "label": "C",
          "text": "2",
          "correct": false
        },
        {
          "label": "D",
          "text": "3",
          "correct": false
        }
      ],
      "correct_answer": "B. 1",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-172340.jpg"
      ],
      "explanation": "<p><strong>Ans. B) 1</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94b9d9a8",
      "audio": ""
    },
    {
      "text": "A 35-year-old male presents with fatigue, weight loss, and splenomegaly. Blood tests reveal an elevated white blood cell count with a predominance of immature myeloid cells. Cytogenetic analysis of the patient's bone marrow cells is most likely to reveal which of the following abnormalities?",
      "options": [
        {
          "label": "A",
          "text": "HER2/ERBB2 amplification",
          "correct": false
        },
        {
          "label": "B",
          "text": "BCR-ABL1 fusion gene",
          "correct": true
        },
        {
          "label": "C",
          "text": "CBFB-MYH11 fusion gene",
          "correct": false
        },
        {
          "label": "D",
          "text": "Polyploidy",
          "correct": false
        }
      ],
      "correct_answer": "B. BCR-ABL1 fusion gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. HER2/ERBB2 amplification is associated with breast and other solid tumors.</li><li>\u2022 Option A. HER2/ERBB2 amplification</li><li>\u2022 Option C. CBFB-MYH11 and FIP1L1-PDGFRA are fusion genes associated with other hematological malignancies.</li><li>\u2022 Option C. CBFB-MYH11 and FIP1L1-PDGFRA</li><li>\u2022 Option D. Polyploidy refers to an increased number of chromosome sets and is not typically seen in CML.</li><li>\u2022 Option D. Polyploidy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The BCR-ABL1 fusion gene is a specific genetic abnormality that is highly diagnostic for CML and serves as a target for tyrosine kinase inhibitor therapy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c0dfdc31",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with ischemic hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated AST, normal ALT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated alkaline phosphatase, normal ALT and AST",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in ischemic hepatitis, where both enzymes are usually elevated.</li><li>\u2022 Option A. Elevated ALT, normal AST</li><li>\u2022 Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with ischemic hepatitis.</li><li>\u2022 Option B. Elevated AST, normal ALT</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than ischemic hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ischemic hepatitis typically presents with marked elevations in both ALT and AST levels, reflecting acute hepatocellular injury due to compromised hepatic perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f60a673",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with acute fulminant Wilson's disease?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated AST, normal ALT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated alkaline phosphatase, normal ALT and AST",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in acute fulminant Wilson's disease, where both enzymes are usually elevated.</li><li>\u2022 Option A. Elevated ALT, normal AST</li><li>\u2022 Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with acute fulminant Wilson's disease.</li><li>\u2022 Option B. Elevated AST, normal ALT</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than acute fulminant Wilson's disease, as alkaline phosphatase levels are typically elevated in cholestasis.</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Acute fulminant Wilson's disease presents with markedly elevated ALT and AST levels, reflecting severe hepatocellular injury and necrosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f06c467e",
      "audio": ""
    },
    {
      "text": "Which of the following calculations is most appropriate to assess the severity and prognosis of alcoholic hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Child-Pugh score",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glasgow Alcoholic Hepatitis Score",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maddrey's Discriminant Function",
          "correct": true
        },
        {
          "label": "D",
          "text": "MELD score",
          "correct": false
        }
      ],
      "correct_answer": "C. Maddrey's Discriminant Function",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Child-Pugh score : While used to assess the severity of liver disease, the Child-Pugh score may not be as specific for alcoholic hepatitis severity as Maddrey's Discriminant Function.</li><li>\u2022 Option A. Child-Pugh score</li><li>\u2022 Option B. Glasgow Alcoholic Hepatitis Score : This scoring system assesses the severity of alcoholic hepatitis but does not specifically incorporate INR, which is a component of Maddrey's Discriminant Function.</li><li>\u2022 Option B. Glasgow Alcoholic Hepatitis Score</li><li>\u2022 Option D. MELD score : The Model for End-Stage Liver Disease (MELD) score is used for liver transplant allocation and does not specifically assess the severity of alcoholic hepatitis.</li><li>\u2022 Option D. MELD score</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Maddrey's Discriminant Function is a valuable tool for assessing the severity and prognosis of alcoholic hepatitis, guiding treatment decisions and predicting mortality in patients with this condition.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "634ffbbe",
      "audio": ""
    },
    {
      "text": "Which of the following histological findings is characteristic of non-alcoholic steatohepatitis (NASH)?",
      "options": [
        {
          "label": "A",
          "text": "Presence of Mallory-Denk bodies",
          "correct": true
        },
        {
          "label": "B",
          "text": "Periportal inflammation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bile duct proliferation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hepatic iron deposition",
          "correct": false
        }
      ],
      "correct_answer": "A. Presence of Mallory-Denk bodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Periportal inflammation : While inflammation is a feature of NASH, it typically involves the lobular region rather than periportal areas.</li><li>\u2022 Option B. Periportal inflammation</li><li>\u2022 Option C. Bile duct proliferation : Bile duct proliferation is not a typical histological finding in NASH and is more suggestive of chronic cholestatic liver diseases.</li><li>\u2022 Option C. Bile duct proliferation</li><li>\u2022 Option D. Hepatic iron deposition : Hepatic iron deposition is not a characteristic histological finding in NASH and is more commonly associated with hereditary hemochromatosis or chronic liver disease.</li><li>\u2022 Option D. Hepatic iron deposition</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Characteristic histological features of NASH, such as Mallory-Denk bodies, helps in the accurate diagnosis and differentiation from other liver diseases, guiding appropriate management strategies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a16ef8d2",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman reports chronic diarrhea, bloating, fatigue, and unexplained weight loss, worsened by consuming gluten-containing foods. She has iron-deficiency anemia and low vitamin D levels. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Irritable Bowel Syndrome (IBS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inflammatory Bowel Disease (IBD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Celiac Disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gastric Ulcer",
          "correct": false
        }
      ],
      "correct_answer": "C. Celiac Disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Celiac Disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Irritable Bowel Syndrome (IBS) : While IBS can cause similar gastrointestinal symptoms, it does not lead to nutrient malabsorption or the specific nutrient deficiencies seen in this patient.</li><li>\u2022 Option A. Irritable Bowel Syndrome (IBS)</li><li>\u2022 Option B. Inflammatory Bowel Disease (IBD) : IBD, including Crohn's disease and ulcerative colitis, could cause similar symptoms and anemia, but the specific worsening with gluten-containing foods and the combination of deficiencies point more towards celiac disease.</li><li>\u2022 Option B. Inflammatory Bowel Disease (IBD)</li><li>\u2022 Option D. Gastric Ulcer : A gastric ulcer might cause pain and anemia due to bleeding, but it would not typically cause the nutrient malabsorption, diarrhea, and specific dietary trigger related to gluten intake.</li><li>\u2022 Option D. Gastric Ulcer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Chronic gastrointestinal symptoms that worsen with gluten ingestion, combined with iron-deficiency anemia and other signs of malabsorption, are suggestive of celiac disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da30e24f",
      "audio": ""
    },
    {
      "text": "A 20-year-old male presents with intermittent episodes of mild jaundice, particularly during periods of stress or fasting. Laboratory tests reveal unconjugated hyperbilirubinemia with normal liver function tests. Which of the following conditions is most likely responsible for the patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Wilson's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gilbert Syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dubin-Johnson syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Gilbert Syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Wilson's disease : Wilson's disease presents with hepatic copper accumulation leading to liver dysfunction, neurological symptoms, and Kayser-Fleischer rings, which are not present in Gilbert Syndrome.</li><li>\u2022 Option A. Wilson's disease</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is associated with abnormal liver function tests reflecting increased bilirubin turnover.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option D. Dubin-Johnson syndrome : Dubin-Johnson syndrome is characterized by conjugated hyperbilirubinemia due to impaired bilirubin excretion into bile, resulting in darkly pigmented liver tissue, which is not seen in Gilbert Syndrome.</li><li>\u2022 Option D. Dubin-Johnson syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The clinical presentation and laboratory findings of Gilbert Syndrome, includes unconjugated hyperbilirubinemia with normal liver function tests.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc089227",
      "audio": ""
    },
    {
      "text": "A 2-week-old neonate presents with severe jaundice since birth. Laboratory tests reveal markedly elevated unconjugated bilirubin levels without evidence of hemolysis or liver dysfunction. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Gilbert Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar Syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dubin-Johnson Syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Crigler-Najjar Syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Gilbert Syndrome : Gilbert Syndrome also presents with unconjugated hyperbilirubinemia but is milder and typically presents later in life.</li><li>\u2022 Option A. Gilbert Syndrome</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia, but it is associated with evidence of hemolysis on laboratory tests, which is not present in Crigler-Najjar Syndrome.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option D. Dubin-Johnson Syndrome : Dubin-Johnson Syndrome presents with conjugated hyperbilirubinemia and is characterized by darkly pigmented liver tissue, which is not seen in Crigler-Najjar Syndrome.</li><li>\u2022 Option D. Dubin-Johnson Syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The clinical presentation and laboratory findings of Crigler-Najjar Syndrome, includes severe unconjugated hyperbilirubinemia without evidence of hemolysis or liver dysfunction, is essential for early diagnosis and appropriate management, which may include phototherapy or liver transplantation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "efecfd2d",
      "audio": ""
    },
    {
      "text": "A 30-year-old female presents with chronic jaundice and dark-colored urine. Laboratory tests reveal elevated levels of conjugated bilirubin and normal liver function tests. Abdominal imaging shows a liver with a characteristic \"black liver\" appearance. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Gilbert Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dubin-Johnson Syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Dubin-Johnson Syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-115621.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Gilbert Syndrome : Gilbert Syndrome presents with unconjugated hyperbilirubinemia due to reduced activity of UDP-glucuronosyltransferase (UGT1A1), without evidence of liver dysfunction or bile pigment deposition.</li><li>\u2022 Option A. Gilbert Syndrome</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is not associated with conjugated hyperbilirubinemia or liver pigment deposition.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option C. Crigler-Najjar Syndrome : Crigler-Najjar Syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), without evidence of liver pigment deposition.</li><li>\u2022 Option C. Crigler-Najjar Syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and characteristic imaging findings of Dubin-Johnson Syndrome, including conjugated hyperbilirubinemia and a \"black liver\" appearance, aids in accurate diagnosis and differentiation from other causes of jaundice.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "67a1d35e",
      "audio": ""
    },
    {
      "text": "A 6-month-old infant presents with persistent jaundice, hepatosplenomegaly, and failure to thrive. Laboratory tests reveal elevated levels of conjugated bilirubin and liver function tests consistent with cholestasis. Abdominal imaging shows no abnormalities. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Wilson's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alagille syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Progressive familial intrahepatic cholestasis (PFIC)",
          "correct": true
        }
      ],
      "correct_answer": "D. Progressive familial intrahepatic cholestasis (PFIC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Wilson's disease : Wilson's disease presents with hepatic copper accumulation leading to liver dysfunction and neurological symptoms, which are not typical features of PFIC.</li><li>\u2022 Option A. Wilson's disease</li><li>\u2022 Option B. Alagille syndrome : Alagille syndrome presents with bile duct paucity, characteristic facial features, and cardiac abnormalities, which are not features of PFIC.</li><li>\u2022 Option B. Alagille syndrome</li><li>\u2022 Option C. Crigler-Najjar syndrome : Crigler-Najjar syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), which is different from the cholestatic presentation seen in PFIC.</li><li>\u2022 Option C. Crigler-Najjar syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of progressive familial intrahepatic cholestasis (PFIC), includes cholestasis with elevated conjugated bilirubin levels and normal or mildly abnormal liver function tests.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e363f314",
      "audio": ""
    },
    {
      "text": "Which of the following best describes a patient's hepatitis B virus (HBV) infection status if he has positive serology for hepatitis B surface antigen (HBsAg) , who has come for a routine check up ?",
      "options": [
        {
          "label": "A",
          "text": "Chronic hepatitis B infection",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute hepatitis B infection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Resolved hepatitis B infection",
          "correct": false
        }
      ],
      "correct_answer": "A. Chronic hepatitis B infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Acute hepatitis B infection : Acute infection is characterized by the presence of HBsAg along with other markers such as IgM anti-HBc and HBV DNA.</li><li>\u2022 Option B. Acute hepatitis B infection</li><li>\u2022 Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative HBeAg.</li><li>\u2022 Option C. Immune control phase</li><li>\u2022 Option D. Resolved hepatitis B infection : Resolved infection is characterized by the presence of anti-HBs and absence of HBsAg.</li><li>\u2022 Option D. Resolved hepatitis B infection</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HBsAg positivity indicates chronic hepatitis B infection that helps in appropriate management and monitoring of patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2244d0fe",
      "audio": ""
    },
    {
      "text": "A 44-year-old male with a history of dyspepsia is referred to gastroenterology for evaluation. What is the most appropriate initial test for Helicobacter pylori in the patient?",
      "options": [
        {
          "label": "A",
          "text": "Urea breath test",
          "correct": true
        },
        {
          "label": "B",
          "text": "Serologic antibody test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stool antigen test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endoscopic biopsy for histology",
          "correct": false
        }
      ],
      "correct_answer": "A. Urea breath test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Urea breath test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Serologic antibody test : This test can indicate past or present infection but cannot distinguish between the two, making it less useful for initial diagnosis or confirmation of eradication.</li><li>\u2022 Option B. Serologic antibody test</li><li>\u2022 Option C. Stool antigen test : Although this test is also non-invasive and has good sensitivity and specificity, the urea breath test is generally preferred due to its rapidity and convenience.</li><li>\u2022 Option C. Stool antigen test</li><li>\u2022 Option D. Endoscopic biopsy for histology : While accurate, endoscopy is invasive and not recommended as an initial test for patients without alarm symptoms.</li><li>\u2022 Option D. Endoscopic biopsy for histology</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For initial testing of Helicobacter pylori in patients with dyspepsia and no alarming features, the non-invasive and accurate urea breath test is the most appropriate choice.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c2c4fa3",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient with chronic hepatitis B infection presents with elevated liver enzymes and detectable HBV DNA levels. The patient has no evidence of cirrhosis or hepatocellular carcinoma. Which of the following is the most appropriate initial treatment according to current guidelines?",
      "options": [
        {
          "label": "A",
          "text": "Lamivudine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interferon-alpha",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tenofovir disoproxil fumarate (TDF)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Adefovir dipivoxil",
          "correct": false
        }
      ],
      "correct_answer": "C. Tenofovir disoproxil fumarate (TDF)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Lamivudine : Lamivudine is an older nucleoside analog and is associated with high rates of resistance, making it a less preferred option for initial treatment.</li><li>\u2022 Option A. Lamivudine</li><li>\u2022 Option B. Interferon-alpha : Interferon-alpha is less commonly used due to its side effect profile and limited efficacy compared to nucleos(t)ide analogs.</li><li>\u2022 Option B. Interferon-alpha</li><li>\u2022 Option D. Adefovir dipivoxil : Adefovir dipivoxil is another nucleotide analog, but it is associated with a higher rate of nephrotoxicity and resistance compared to TDF or entecavir.</li><li>\u2022 Option D. Adefovir dipivoxil</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The current treatment guidelines for chronic hepatitis B infection, includes the preference for nucleos(t)ide analogs such as tenofovir disoproxil fumarate (TDF) or entecavir as initial therapy that aids in appropriate management and prevention of disease progression.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "97ffc3c8",
      "audio": ""
    },
    {
      "text": "Which of the following are confirmatory tests for active HCV infection?",
      "options": [
        {
          "label": "A",
          "text": "HCV RNA PCR",
          "correct": true
        },
        {
          "label": "B",
          "text": "HCV core antigen assay",
          "correct": false
        },
        {
          "label": "C",
          "text": "HCV genotyping",
          "correct": false
        },
        {
          "label": "D",
          "text": "Liver biopsy",
          "correct": false
        }
      ],
      "correct_answer": "A. HCV RNA PCR",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. The HCV core antigen assay can be used as an alternative to HCV RNA PCR in some cases to confirm active infection, but HCV RNA PCR remains the gold standard for confirming active HCV replication.</li><li>\u2022 Option B.</li><li>\u2022 Option C. HCV genotyping is important for determining the genotype of the HCV virus, which can influence treatment decisions. However, it is not the initial confirmatory test for active infection; it is typically done after confirming active infection with HCV RNA PCR.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Liver biopsy is an invasive procedure used to assess liver damage and is not used as a confirmatory test for active HCV infection. It may be used in certain clinical scenarios to assess the extent of liver fibrosis or cirrhosis but is not necessary for the initial diagnosis of HCV.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HCV RNA PCR is the confirmatory test for active infection following positive anti-HCV antibody serology that aids in accurate diagnosis and appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f70482a1",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient presents tests positive for anti-HCV antibodies and elevated liver enzymes. Which of the following statements regarding HCV serology is correct?",
      "options": [
        {
          "label": "A",
          "text": "Anti-HCV antibodies indicate active HCV infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "HCV RNA PCR is not necessary if anti-HCV antibodies are positive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Resolved HCV infection is characterized by positive HCV RNA PCR",
          "correct": false
        },
        {
          "label": "D",
          "text": "HCV core antigen assay is used to detect prior HCV exposure",
          "correct": true
        }
      ],
      "correct_answer": "D. HCV core antigen assay is used to detect prior HCV exposure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti-HCV antibodies indicate exposure to the HCV virus but do not differentiate between active and resolved infections. The presence of antibodies alone cannot confirm active HCV infection.</li><li>\u2022 Option A.</li><li>\u2022 Option B . HCV RNA PCR testing is necessary to confirm active HCV infection even if anti-HCV antibodies are positive. This is because anti-HCV antibodies can be present in both active and resolved infections.</li><li>\u2022 Option B</li><li>\u2022 Option C. Resolved HCV infection is characterized by the presence of anti-HCV antibodies without detectable HCV RNA. The absence of HCV RNA indicates that the virus is not currently replicating in the patient's body.</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 HCV core antigen assay helps to detect prior HCV exposure, that aids in accurate diagnosis and management of hepatitis C virus (HCV) infection.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a4de656",
      "audio": ""
    },
    {
      "text": "For a 55-year-old female with chronic HCV infection genotype 2, without cirrhosis, what is the most appropriate treatment regimen?",
      "options": [
        {
          "label": "A",
          "text": "Ledipasvir/Sofosbuvir for 12 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sofosbuvir/Velpatasvir for 12 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "Elbasvir/Grazoprevir for 12 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sofosbuvir and ribavirin for 24 weeks",
          "correct": false
        }
      ],
      "correct_answer": "B. Sofosbuvir/Velpatasvir for 12 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ledipasvir/sofosbuvir is highly effective in treating HCV genotype 1 infections but is not the first choice for genotype 2.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Elbasvir/grazoprevir is primarily used for HCV genotype 1 and 4 infections, and thus not the optimal choice for genotype 2.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Sofosbuvir and ribavirin for 24 weeks is an older regimen that may be considered in certain contexts for genotype 2 but is less preferable due to the longer treatment duration and side effects associated with ribavirin.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The efficacy of sofosbuvir/velpatasvir for 12 weeks helps  in treating HCV genotype 2 infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc9886f5",
      "audio": ""
    },
    {
      "text": "A 35-year-old female presents with fatigue, jaundice, and abdominal discomfort for the past few weeks. Laboratory tests reveal elevated liver enzymes, hypergammaglobulinemia, and positive antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA). What is the most likely diagnosis based on these findings?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic hepatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Autoimmune hepatitis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Primary biliary cholangitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Autoimmune hepatitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alcoholic hepatitis : While alcoholic hepatitis can present with similar symptoms, it is typically associated with a history of excessive alcohol consumption and may not have the characteristic autoantibodies seen in autoimmune hepatitis.</li><li>\u2022 Option A. Alcoholic hepatitis</li><li>\u2022 Option B. Non-alcoholic fatty liver disease (NAFLD) : NAFLD typically presents with elevated liver enzymes and fatty infiltration of the liver but lacks the characteristic autoimmune serological markers seen in autoimmune hepatitis.</li><li>\u2022 Option B. Non-alcoholic fatty liver disease (NAFLD)</li><li>\u2022 Option D. Primary biliary cholangitis : Primary biliary cholangitis may present with similar symptoms, but it is characterized by the presence of anti-mitochondrial antibodies (AMA) and histological features of bile duct damage, which are not seen in autoimmune hepatitis.</li><li>\u2022 Option D. Primary biliary cholangitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of autoimmune hepatitis, includes elevated liver enzymes, hypergammaglobulinemia, and positive autoantibodies (ANA and ASMA).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ccd8fda8",
      "audio": ""
    },
    {
      "text": "What is the most appropriate initial treatment regimen for H. pylori infection in a patient with no prior antibiotic exposure and no contraindications is triple therapy?",
      "options": [
        {
          "label": "A",
          "text": "Clarithromycin, amoxicillin, and omeprazole",
          "correct": true
        },
        {
          "label": "B",
          "text": "Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amoxicillin, ciprofloxacin, and ranitidine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metronidazole, ciprofloxacin, and lansoprazole",
          "correct": false
        }
      ],
      "correct_answer": "A. Clarithromycin, amoxicillin, and omeprazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Clarithromycin, amoxicillin, and omeprazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole : This quadruple therapy is an alternative, particularly in areas of high clarithromycin resistance or for patients with previous macrolide exposure.</li><li>\u2022 Option B. Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole</li><li>\u2022 Option C. Amoxicillin, ciprofloxacin, and ranitidine : This combination is not a standard regimen for H. pylori eradication and includes a fluoroquinolone and an H2 blocker, which is less effective than a proton pump inhibitor in this setting.</li><li>\u2022 Option C. Amoxicillin, ciprofloxacin, and ranitidine</li><li>\u2022 Option D. Metronidazole, ciprofloxacin, and lansoprazole : This regimen does not follow the recommended guidelines for H. pylori treatment due to the inclusion of ciprofloxacin, which is not a first-line agent for this infection.</li><li>\u2022 Option D. Metronidazole, ciprofloxacin, and lansoprazole</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The initial treatment for H. pylori infection should consist of triple therapy with a proton pump inhibitor (like omeprazole) and two antibiotics (clarithromycin and amoxicillin) for 14 days to effectively eradicate the infection and promote ulcer healing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22396949",
      "audio": ""
    },
    {
      "text": "A 55-year-old female presents with fatigue, pruritus, and right upper quadrant abdominal pain. Laboratory tests show elevated alkaline phosphatase and positive anti-mitochondrial antibodies (AMA). Abdominal imaging reveals hepatomegaly and features suggestive of intrahepatic cholestasis. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic liver disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary biliary cholangitis (PBC)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Autoimmune hepatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": false
        }
      ],
      "correct_answer": "B. Primary biliary cholangitis (PBC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alcoholic liver disease : Alcoholic liver disease typically presents with a history of alcohol abuse and may have elevated liver enzymes but lacks the characteristic AMA positivity seen in PBC.</li><li>\u2022 Option A. Alcoholic liver disease</li><li>\u2022 Option C. Autoimmune hepatitis : Autoimmune hepatitis may present with similar symptoms but is characterized by elevated transaminases and positive antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA), rather than AMA.</li><li>\u2022 Option C. Autoimmune hepatitis</li><li>\u2022 Option D. Non-alcoholic fatty liver disease (NAFLD): NAFLD typically presents with features of metabolic syndrome and may have elevated liver enzymes, but it does not typically present with pruritus or positive AMA.</li><li>\u2022 Option D. Non-alcoholic fatty liver disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of primary biliary cholangitis (PBC), includes pruritus, elevated alkaline phosphatase, and positive anti-mitochondrial antibodies (AMA).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6dd99108",
      "audio": ""
    },
    {
      "text": "A 45-year-old male presents with fatigue, pruritus, and jaundice. Laboratory tests reveal elevated alkaline phosphatase and serum bilirubin levels. Imaging studies show multifocal strictures and dilatations of the intrahepatic and extrahepatic bile ducts. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic liver disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary sclerosing cholangitis (PSC)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Autoimmune hepatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": false
        }
      ],
      "correct_answer": "B. Primary sclerosing cholangitis (PSC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alcoholic liver disease typically presents with a history of significant alcohol consumption and can lead to a spectrum of liver abnormalities, including steatosis, alcoholic hepatitis, and cirrhosis, but it does not typically present with the specific bile duct changes seen in PSC.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Autoimmune hepatitis is characterized by inflammation of the liver due to an autoimmune response and is often associated with elevated transaminases and positive autoimmune markers, which are not the primary findings in this case.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Non-alcoholic fatty liver disease (NAFLD) is associated with metabolic risk factors such as obesity, diabetes, and hyperlipidemia and primarily affects the liver parenchyma, leading to steatosis and potentially steatohepatitis, but it does not cause the bile duct abnormalities seen in PSC.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation of fatigue, pruritus, jaundice, elevated alkaline phosphatase, and serum bilirubin levels, along with characteristic imaging findings of multifocal strictures and dilatations of bile ducts, is typical of primary sclerosing cholangitis (PSC).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9137d57e",
      "audio": ""
    },
    {
      "text": "What histopathological feature is characteristic of primary sclerosing cholangitis (PSC) ?",
      "options": [
        {
          "label": "A",
          "text": "Steatosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mallory-Denk bodies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Granulomas",
          "correct": false
        },
        {
          "label": "D",
          "text": "Onion-skinning",
          "correct": true
        }
      ],
      "correct_answer": "D. Onion-skinning",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-174600.jpg"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Steatosis, or the accumulation of fat within liver cells, is a feature more commonly associated with conditions like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, not PSC.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Mallory-Denk bodies are cytoplasmic inclusions found in liver cells, typically associated with alcoholic liver disease and not characteristic of PSC.</li><li>\u2022 Option B.</li><li>\u2022 Option C. Granulomas are aggregates of macrophages and are more typically associated with conditions such as sarcoidosis or granulomatous hepatitis, not specifically characteristic of PSC.</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Onion-skinning, characterized by concentric fibrosis and inflammation around bile ducts, is a characteristic histopathological feature of primary sclerosing cholangitis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c38faab8",
      "audio": ""
    },
    {
      "text": "What scoring system is commonly used for the initial assessment and diagnosis of Wilson Disease?",
      "options": [
        {
          "label": "A",
          "text": "Child-Pugh Score",
          "correct": false
        },
        {
          "label": "B",
          "text": "MELD Score",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nazer Score",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ranson's Criteria",
          "correct": false
        }
      ],
      "correct_answer": "C. Nazer Score",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A . The Child-Pugh Score is used to assess the prognosis of chronic liver disease, mainly cirrhosis, and to determine the required strength of treatment and the need for liver transplantation.</li><li>\u2022 Option A</li><li>\u2022 Option B . The MELD Score (Model for End-Stage Liver Disease) is used to prioritize patients for liver transplantation, based on the severity of chronic liver disease.</li><li>\u2022 Option B</li><li>\u2022 Option D. Ranson's Criteria are used to assess the severity of acute pancreatitis and predict its outcome.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The Nazer Score is a scoring system used for the initial assessment and diagnosis of Wilson Disease, incorporating clinical, biochemical, and histological parameters relevant to the disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "16d688b1",
      "audio": ""
    }
  ]
}